sub:assertion {
  sub:association rdf:object <https://identifiers.org/MONDO:0005090> ;
    rdf:predicate biolink:treats ;
    rdf:subject <https://go.drugbank.com/drugs/DB00107> ;
    a rdf:Statement ;
    rdfs:label "A retrospective chart review evaluated outcomes for 5 young adult inpatients with treatment-resistant schizophrenia who were prescribed off-label oxytocin (OT; 10 IU/sublingual, 1 time per day, to 20 IU/sublingual, 3 times per day) after their therapeutic response to clozapine plateaued (dose range: 200 to 600 mg). The augmented treatment was well tolerated and continued for at least 1 year after discharge from the hospital, with continued outpatient follow-up by the treating psychiatrist. Evaluation included the Positive and Negative Syndrome Scale and clinical review based on both self and parent/guardian reports." ;
    biolink:association_type biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    biolink:provided_by <https://w3id.org/um/NeuroDKG> ;
    biolink:publications <https://pubmed.ncbi.nlm.nih.gov/32343282> ;
    biolink:relation nkg:OffLabelIndication .
  <https://go.drugbank.com/drugs/DB00107> biolink:category biolink:Drug .
  <https://identifiers.org/MONDO:0005090> biolink:category biolink:Disease .
}